Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients

[1]  T. Eleftheriadis,et al.  Plasma Indoleamine 2,3-Dioxygenase and Arginase Type I May Contribute to Decreased Blood T-Cell Count in Hemodialysis Patients , 2012, Renal failure.

[2]  T. Eleftheriadis,et al.  Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. , 2012, Iranian journal of kidney diseases.

[3]  S. L. Bridal,et al.  RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation , 2012, The Journal of Immunology.

[4]  L. Glimcher,et al.  Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. , 2011, The Journal of clinical investigation.

[5]  T. Eleftheriadis,et al.  Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination. , 2011, Vaccine.

[6]  T. Berney,et al.  Immunomodulation by blockade of the TRANCE co‐stimulatory pathway in murine allogeneic islet transplantation , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  H. Takayanagi,et al.  The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. , 2008, Immunity.

[8]  L. Xing,et al.  Functions of RANKL/RANK/OPG in bone modeling and remodeling. , 2008, Archives of biochemistry and biophysics.

[9]  T. Eleftheriadis,et al.  Chronic Inflammation and T Cell Zeta-Chain Downregulation in Hemodialysis Patients , 2007, American Journal of Nephrology.

[10]  A. Kostakis,et al.  sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients , 2007, Journal of endocrinological investigation.

[11]  J. Penninger,et al.  RANK signals from CD4+3− inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla , 2007, The Journal of Experimental Medicine.

[12]  T. Eleftheriadis,et al.  Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients , 2007, Seminars in dialysis.

[13]  L. Hofbauer,et al.  Osteoprotegerin expression in dendritic cells increases with maturation and is NF‐κB‐dependent , 2007, Journal of cellular biochemistry.

[14]  M. Shaarawy,et al.  Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure. , 2007, Clinical chemistry and laboratory medicine.

[15]  J. Penninger,et al.  Receptor Activator of NF-κB Ligand and Osteoprotegerin Regulate Proinflammatory Cytokine Production in Mice1 , 2006, The Journal of Immunology.

[16]  C. de la Piedra,et al.  Association between phosphate removal and markers of bone turnover in haemodialysis patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  T. Eleftheriadis,et al.  The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  R. Nuti,et al.  Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis , 2005, Journal of endocrinological investigation.

[19]  J. Marc,et al.  Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  A. Grzegorzewska,et al.  Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients. , 2005, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[21]  T. Eleftheriadis,et al.  Impaired T Cell Proliferation and Zeta Chain Phosphorylation after Stimulation with Staphylococcal Enterotoxin-B in Hemodialysis Patients , 2004, Nephron Clinical Practice.

[22]  G. Morgan,et al.  Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. , 2003, Immunity.

[23]  M. Ostrowski,et al.  Cooperation of TNF Family Members CD40 Ligand, Receptor Activator of NF-κB Ligand, and TNF-α in the Activation of Dendritic Cells and the Expansion of Viral Specific CD8+ T Cell Memory Responses in HIV-1-Infected and HIV-1-Uninfected Individuals 1 , 2003, The Journal of Immunology.

[24]  D. Adams,et al.  Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. , 2002, Blood.

[25]  J. Wauters,et al.  Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[26]  G. Boltz‐Nitulescu,et al.  Impaired T cell proliferation, increased soluble death‐inducing receptors and activation‐induced T cell death in patients undergoing haemodialysis , 2001, Clinical and experimental immunology.

[27]  S. Herring,et al.  Osteoprotegerin, a Crucial Regulator of Bone Metabolism, Also Regulates B Cell Development and Function1 , 2001, The Journal of Immunology.

[28]  M. Monier‐Faugere,et al.  The role of bone biopsy in clinical practice and research. , 1999, Kidney international. Supplement.

[29]  R. Steinman,et al.  TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. , 1999, Journal of immunology.

[30]  B. Seckler,et al.  Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. , 1998, Chest.

[31]  R. Steinman,et al.  TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor , 1997, The Journal of experimental medicine.

[32]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[33]  H. Kirchner,et al.  Low efficiency of active immunization against diphtheria in chronic hemodialysis patients. , 1997, Kidney international.

[34]  K. Meyer zum Büschenfelde,et al.  Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. , 1986, Kidney international.

[35]  E. Friedman,et al.  Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes. , 1980, JAMA.